2023 Speakers

Adilia Hormigo

Leader of the Neuro-Oncology Program, Professor in the Departments of Oncology, Neurosurgery and Microbiology and Immunology

Albert Einstein College of Medicine

Analiz Rodriguez

Associate Professor, Dept. of Neurosurgery, Director of Neuro-Oncology

University of Arkansas for Medical Sciences

Anna Golebiewska

Group Leader, NORLUX Neuro-Oncology Laboratory

Luxembourg Institute of Health

Benjamin Ellingson

Director of the UCLA Brain Tumor Imaging Laboratory

UCLA Radiology

David Arons

Chief Executive Officer

National Brain Tumor Society

Dennis Brown

Chief Scientific Officer

Kintara Therapeutics

Erik Sulman

Professor

NYU Grossman School of Medicine

Fahar Merchant

Chief Executive Officer and President

Medicenna

Francesca Barone

Chief Scientific Officer

Candel Therapeutics

Hans Clevers

Head of Pharma Research and Early Development

Roche

Henry Smilowitz

Associate Professor

University of Connecticut Health Center

James Crapo

Chief Executive Officer

BioMimetix

James Garner

Chief Executive Officer

Kazia Therapeutics Limited

Jeffrey Skolnik

Vice President - Clinical Development

Inovio Pharmaceuticals

Joanne Smith-Farrell

Chief Executive Officer

Be Biopharma

John de Groot

Division Chief, Neuro- Oncology

UCSF Department of Neurosurgery

Jorge Benitez

Principal Scientist

Bristol Myers Squibb

Josh Allen

CTO

Chimerix Inc

Khalil Barrage

Managing Director, Public Equities

Invus Financial Advisors LLC

Kingson Lin

Co-founder

Modifi Bio

Kiran Reddy

Senior Managing Director

Blackstone Life Sciences Fund

Kirk Tanner

CSO and SVP Brain Tumor Investment Fund

National Brain Tumor Society

Klaus Veitinger

Venture Partner

OrbiMed Advisors

Lizabeth Leveille

Vice President and Head, Boston & European Innovation Hubs & Discovery Transactions

Merck & Co

Louis-Marie Bachelot

Chief Executive Officer

Gliocure

Marnix Bosch

Chief Technical Officer

Northwest Biotherapeutics

Meredith Buxton

CEO

Global Coalition for Adaptive Research

Michael Andriole

Chief Financial Officer & Chief Business Officer

Chimerix Inc

Monika Buczek

Director - Business Development

Certis Oncology

Natalie Artzi

Assistant Professor of Medicine

Harvard Medical School

Nino Chiocca

Co-Director

Institute for the Neurosciences Brigham And Women's Hospita

Patrick Wen

Director - Center For Neuro-Oncology

Dana-Farber Cancer Institute

Paul Peter Tak

Chief Executive Officer & President

Candel Therapeutics

Peter Kolchinsky

Managing Partner

RA Capital Management

Petra Hamerlik

Director

AstraZeneca

Rob Murray

CBO

Global Coalition for Adaptive Research

Robbie Huffines

Global Chairman of Investment Banking

JP Morgan Chase

Samuel rabkin

prof

Harvard Medical School

Santosh Kesari

Director of Neuro-Oncology

Pacific Neuroscience Institute

Sara Piccirillo

Assistant Professor

University of New Mexico

Scott Rakestraw

President

The Branta Group

Sean Lawler

Associate Professor of Pathology and Laboratory Medicine

Brown University

Ted Ashburn

Chief Executive Officer

Oncorus

Timothy Stuhlmiller

Vice President of Scientific and Medical Affairs

XCures

Vijay Agarwal

Chief Executive Officer

Alpheus Medical

Xiao-Nan Li

Rachelle and Mark Gordon Professor of Cancer Research Professor of Pediatrics

Northwestern Medicine

Xiling Shen

Chief Scientific Officer

Terasaki Institute

Next Page: Pre-Conference Workshop Day